F013 1-Year treatment with orlistat produces clinically significant weight loss
نویسندگان
چکیده
منابع مشابه
Review: orlistat and sibutramine are modestly effective for weight loss at 1 year.
and commentary also appear in ACP Journal Club. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Dr R Padwal, University of Alberta and Walter C. Mackenzie Health Sciences Centre, Edmonton, Alberta, Canada. rpadwal@ ualberta.ca Source of funding: no external funding. Orlistat (Orl) or sibutramine (Sib) ...
متن کاملIs 5% weight loss a satisfactory criterion to define clinically significant weight loss?
The idea of quantitative measurement came to obesity in stages. Quetelet (1) introduced the body mass index (BMI) which was applied nearly a century later to the evaluation of degree of overweight in studies of familial inheritance of obesity. Publication of average weight tables in the 1850s was expanded to “ideal” weight tables by the life insurance industry in the mid-20th century. The relat...
متن کاملOrlistat and sibutramine beyond weight loss.
BACKGROUND AND AIM To investigate, through a meta-analysis of clinical trials, the effect of two weight-reducing drugs, such as orlistat and sibutramine, on serum lipid profiles in overweight and obese subjects, independently of weight loss. METHODS A systematic search strategy, incorporating the terms orlistat, sibutramine, fat, cholesterol, lipid profile, cardiovascular risk, was developed ...
متن کاملSignificant Neonatal Weight Loss Related to Idiopathic Neonatal Hyperbilirubinemia
Introduction: Inadequate intake of breast milk in the first days of life leads to weight loss in neonates. Jaundice is also more prominent in these infants. In this cross-sectional study, we tried to evaluate the extent of weight loss in term breastfed infants who were hospitalized for idiopathic hyperbilirubinemia. Methods: This prospective study involved 1072 infants >48 hours old, who were ...
متن کاملTaking Orlistat: Predicting Weight Loss over 6 Months
This study explored the predictors of weight loss following orlistat with a focus on both baseline variables and changes in beliefs and behaviours occurring over the course of taking the drug. Patients (n = 566) prescribed orlistat completed a questionnaire at baseline and after 6 months concerning their weight, beliefs and behaviours. By 6 months the majority had lost some weight and showed im...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Hypertension
سال: 1998
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(97)91209-7